• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Working capacity is increased following recombinant human erythropoietin treatment.

作者信息

Mayer G, Thum J, Cada E M, Stummvoll H K, Graf H

机构信息

2nd Department of Medicine, University of Vienna, Austria.

出版信息

Kidney Int. 1988 Oct;34(4):525-8. doi: 10.1038/ki.1988.213.

DOI:10.1038/ki.1988.213
PMID:3199672
Abstract

To investigate the effect of partial correction of anemia in patients maintained by chronic intermittent hemodialysis on aerobic and anaerobic working capacity, eight patients underwent a bicycle spiro-ergometry before and after treatment with recombinant human erythropoietin (r-HuEPO). the initial mean (+/- SD) hemoglobin value was 5.9 mg/dl +/- 0.61 and increased during treatment to 10.9 +/- 0.59 mg/dl, P less than 0.0001). This partial correction of anemia resulted in a significant increase of both oxygen uptake at the anaerobic threshold and peak peripheral oxygen uptake at subjective exhaustion (P less than 0.01 and P less than 0.0002, respectively). The increase in oxygen uptake corresponded to significant increases in Watts, both at the anaerobic threshold and at maximum workload (P less than 0.02 and P less than 0.0004). These data show that partial correction of renal anemia results in a significant increase of both exercise capacity and maximum work.

摘要

相似文献

1
Working capacity is increased following recombinant human erythropoietin treatment.
Kidney Int. 1988 Oct;34(4):525-8. doi: 10.1038/ki.1988.213.
2
[Aerobic and anaerobic capacity of chronic hemodialysis patients under continuous therapy with recombinant human erythropoietin].接受重组人促红细胞生成素持续治疗的慢性血液透析患者的有氧和无氧能力
Nephron. 1989;51 Suppl 1:34-8. doi: 10.1159/000185569.
3
Effects of recombinant human erythropoietin and exercise training on exercise capacity in hemodialysis patients.
Artif Organs. 1995 Dec;19(12):1262-8. doi: 10.1111/j.1525-1594.1995.tb02297.x.
4
Mechanisms of improved physical performance of chronic hemodialysis patients after erythropoietin treatment.
Am J Nephrol. 1990;10 Suppl 2:15-8; discussion 18-23. doi: 10.1159/000168211.
5
Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.重组人促红细胞生成素治疗后血液透析患者的运动
Nephron. 1991;58(3):315-9. doi: 10.1159/000186443.
6
Exercise tolerance after anaemia correction with recombinant human erythropoietin in end-stage renal disease.终末期肾病患者使用重组人促红细胞生成素纠正贫血后的运动耐量
Pediatr Nephrol. 1990 Nov;4(6):623-6. doi: 10.1007/BF00858638.
7
[Ergometric results of r-erythropoietin treatment of hemodialysis patients].[促红细胞生成素治疗血液透析患者的测力计测试结果]
Z Gesamte Inn Med. 1990 May 15;45(10):274-7.
8
Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure.
Am J Cardiol. 1991 Oct 15;68(10):1060-6. doi: 10.1016/0002-9149(91)90496-8.
9
Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin.接受促红细胞生成素治疗的血液透析患者红细胞2,3-二磷酸甘油酸水平升高。
Nephrol Dial Transplant. 1993;8(11):1219-22.
10
Effects of rHuEPO therapy on exercise capacity in hemodialysis patients with coronary artery disease.重组人促红细胞生成素治疗对冠心病血液透析患者运动能力的影响。
Jpn Circ J. 1993 Feb;57(2):131-7. doi: 10.1253/jcj.57.131.

引用本文的文献

1
Preoperative Correction of Low Hemoglobin Levels Can Reduce 1-Year All-Cause Mortality in Osteoporotic Hip Fracture Patients: A Retrospective Observational Study.术前纠正低血红蛋白水平可降低骨质疏松性髋部骨折患者 1 年全因死亡率:一项回顾性观察研究。
Clin Interv Aging. 2022 Feb 17;17:165-173. doi: 10.2147/CIA.S354519. eCollection 2022.
2
A Systematic Method to Detect the Metabolic Threshold from Gas Exchange during Incremental Exercise.一种在递增运动期间从气体交换中检测代谢阈值的系统方法。
J Sports Sci Med. 2017 Aug 8;16(3):396-406. eCollection 2017 Sep.
3
Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?
在临床病房中应用人工神经网络会帮助肾病学家预测促红细胞生成素的反应性吗?
BMC Nephrol. 2006 Sep 18;7:13. doi: 10.1186/1471-2369-7-13.
4
Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.检测作为一种药理学上的促力辅助剂的DNA重组人促红细胞生成素α。
Sports Med. 2002;32(2):125-42. doi: 10.2165/00007256-200232020-00004.
5
Central and peripheral adaptations to physical training in patients with end-stage renal disease.终末期肾病患者对体育锻炼的中枢和外周适应性
Sports Med. 2001;31(9):651-65. doi: 10.2165/00007256-200131090-00002.
6
Quality of life in predialytic uremic patients.透析前尿毒症患者的生活质量。
Qual Life Res. 1996 Feb;5(1):109-16. doi: 10.1007/BF00435975.
7
31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients.31P磁共振波谱法评估肾衰竭患者骨骼肌氧化代谢异常情况
J Clin Invest. 1993 Feb;91(2):420-4. doi: 10.1172/JCI116217.
8
Treatment of the anaemia of chronic renal failure with recombinant human erythropoietin.重组人促红细胞生成素治疗慢性肾衰竭贫血
Drugs. 1989 Sep;38(3):342-5. doi: 10.2165/00003495-198938030-00002.
9
Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.促红细胞生成素(重组人促红细胞生成素)。对其药效学和药代动力学特性以及在贫血和刺激红细胞生成方面的治疗潜力的综述。
Drugs. 1989 Dec;38(6):863-99. doi: 10.2165/00003495-198938060-00004.
10
Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm.使用重组人促红细胞生成素治疗肾性贫血:实用指南及临床算法
BMJ. 1990 Mar 10;300(6725):655-9. doi: 10.1136/bmj.300.6725.655.